Schroder Investment Management Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Sell
218,130
-49,017
-18% -$941K ﹤0.01% 783
2026
Q1
$4.5M Sell
267,147
-75,569
-22% -$1.52M ﹤0.01% 798
2025
Q4
$6.59M Buy
342,716
+3,857
+1% +$69.3K 0.01% 709
2025
Q3
$5.91M Buy
338,859
+90,696
+37% +$1.34M ﹤0.01% 743
2025
Q2
$3.44M Buy
248,163
+55,314
+29% +$891K ﹤0.01% 836
2025
Q1
$3.53M Buy
+192,849
New +$2.88M ﹤0.01% 825
2023
Q1
Sell
-41,402
Closed -$487K 1254
2022
Q4
$487K Buy
+41,402
New +$504K ﹤0.01% 1150

Other funds holding ALHC

Schroder Investment Management Group's ALHC Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Alignment Healthcare (ALHC) stake by 18% in Q2 2026, selling an estimated $941K and leaving 218,130 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Schroder Investment Management Group first reported a position in ALHC in Q4 2022 and has held it in 7 quarters since. The position peaked at $6.59M in Q4 2025. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Schroder Investment Management Group held 218,130 shares of Alignment Healthcare worth $5.07M as of Q2 2026.
  • Schroder Investment Management Group sold 49,017 Alignment Healthcare shares in Q2 2026, an estimated $941K.
  • Alignment Healthcare made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #783 holding.
  • Schroder Investment Management Group first reported a position in Alignment Healthcare in Q4 2022 and has held it in 7 quarters since.
  • Schroder Investment Management Group's Alignment Healthcare position peaked at $6.59M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.